SU5416 in Treating Patients With Metastatic or Locally Recurrent Colorectal Cancer
Status:
Terminated
Trial end date:
2009-08-01
Target enrollment:
Participant gender:
Summary
Phase II trial to study the effectiveness of SU5416 in treating patients who have metastatic
or locally recurrent colorectal cancer. SU5416 may stop the growth of colorectal cancer by
stopping blood flow to the tumor.